Stay updated on Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T20:50:00.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed. This reflects standard version-tracking activity on the record rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-19T22:06:58.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the record history, while the previous v3.6.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-08-29T19:18:17.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The Study Record History now shows a new revision v3.6.5, superseding the previous v3.6.4. This indicates that the study record has been updated.
    Difference
    0.1%
    Check dated 2026-08-08T10:00:12.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 has been added to the study record history, indicating an update to the record; the prior revision v3.6.3 is removed from the visible history.
    Difference
    0.1%
    Check dated 2026-07-25T06:24:20.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The history gains a new revision entry for v3.6.3 and removes the prior v3.6.2, signaling that the record was updated to a newer version.
    Difference
    0.1%
    Check dated 2026-07-03T22:03:13.000Z thumbnail image

Stay in the know with updates to Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.